Patent Assignment
Reel/Frame 038007/0882
Change of Name
Recorded: 2016-03-04
Pages: 3
Assignor
BIOGEN IDEC INC.
Executed: 2015-03-23
Assignee
BIOGEN INC.
250 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(4)
Combination Therapies for B-Cell Lymphomas Comprising Administration of Anti-CD20 Antibody
Patent:
6,455,043 →
Application:
09/372,202 →
Combination Therapies for B-Cell Lymphomas Comprising Administration of Anti-CD20 Antibody
Application:
14/070,256 →
Publication:
US 2014/0056887
Use of Chimeric Anti-CD20 Antibody as in Vitro or in Vivo Purging Agent in Patients Receiving Bmt or Pbsc Transplant
Application:
14/154,956 →
Publication:
US 2014/0363424
Treatment of Diffuse Large-Cell Lymphoma with Anti-CD20 Antibody
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 6, 1999
From: GRILLO-LOPEZ, ANTONIO J.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 010292/0939 →
Assignment of Assignor's Interest
Feb 23, 2016
From: WHITE, CHRISTINE; GRILLO-LOPEZ, ANTONIO
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 037799/0825 →
Assignment of Assignor's Interest
Feb 23, 2016
From: GRILLO-LOPEZ, ANTONIO J.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 037800/0419 →
Change of Name
Feb 23, 2016
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 037882/0630 →
Assignment of Assignor's Interest
Feb 23, 2016
From: GRILLO-LOPEZ, ANTONIO J.; LEONARD, JOHN
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 037799/0636 →
Change of Name
Feb 25, 2016
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 037917/0874 →
Change of Name
Feb 25, 2016
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 037917/0877 →
Change of Name
Feb 25, 2016
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 037917/0815 →